| |
| |
|
| Insider
Information: |
Kohli Aditya |
| Relationship: |
|
| City: |
Buffalo Grove |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,626,230 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,279,188 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,626,230 |
|
|
| Total
Value |
$10,279,188 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Phathom Pharmaceuticals, Inc. |
PHAT |
Officer |
2019-10-24 |
843,352 |
|
0 |
Premium* |
|
|
Hillevax, Inc. |
HLVX |
|
2024-05-03 |
782,878 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-05-03 |
4 |
AS |
$14.15 |
$10,233 |
D/D |
(723) |
782,878 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-05-02 |
4 |
AS |
$14.01 |
$84,081 |
D/D |
(6,000) |
783,601 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-05-01 |
4 |
AS |
$14.03 |
$2,456 |
D/D |
(175) |
789,601 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-04-05 |
4 |
AS |
$14.44 |
$86,640 |
D/D |
(6,000) |
789,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-04-04 |
4 |
AS |
$14.71 |
$88,245 |
D/D |
(6,000) |
795,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-04-03 |
4 |
AS |
$14.93 |
$89,582 |
D/D |
(6,000) |
801,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-03-20 |
4 |
AS |
$164,221.00 |
$985,326,000 |
D/D |
(6,000) |
807,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-03-19 |
4 |
AS |
$17.42 |
$104,492 |
D/D |
(6,000) |
813,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-03-18 |
4 |
AS |
$17.66 |
$105,937 |
D/D |
(6,000) |
819,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-03-08 |
4 |
AS |
$18.66 |
$111,959 |
D/D |
(6,000) |
825,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-03-07 |
4 |
AS |
$18.37 |
$110,213 |
D/D |
(6,000) |
831,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-03-06 |
4 |
AS |
$18.95 |
$113,701 |
D/D |
(6,000) |
837,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-02-22 |
4 |
AS |
$15.05 |
$90,312 |
D/D |
(6,000) |
843,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-02-21 |
4 |
AS |
$14.92 |
$89,495 |
D/D |
(6,000) |
849,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-02-20 |
4 |
AS |
$14.88 |
$89,272 |
D/D |
(6,000) |
855,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-02-12 |
4 |
AS |
$15.32 |
$91,921 |
D/D |
(6,000) |
861,776 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-02-08 |
4 |
S |
$14.93 |
$132,383 |
D/D |
(8,866) |
812,878 |
0 |
% |
|
| HLVX |
Hillevax, Inc. |
|
– • – |
2024-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
54,898 |
867,776 |
0 |
- |
|
| HLVX |
Hillevax, Inc. |
Chief Operating Officer |
• • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
85,466 |
821,744 |
0 |
- |
|
| HLVX |
Hillevax, Inc. |
Chief Operating OfficerOfficer |
• • – |
2022-04-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
736,278 |
|
- |
|
| PHAT |
Phathom Pharmaceuticals, ... |
Chief Business OfficerOfficer |
• – – |
2019-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
843,352 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
